Evaluation In- Network & Out-of-Network Pharmacy Trends
Out-of-network prescriptions represent an area of additional opportunity for clinical and cost controls and can often be associated with high-cost drugs. Leveraging both bill review and pharmacy data provides additional visibility into transactions from third-party billers, physician-dispensers, and co-mingled hospital and office visit bills. This analysis features the trends experienced within our combined in- and out-of-network channels to identify a total view of prescription activity.
To view future installments of the drug trends series, be sure to visit our drug trends page.
To learn more from Enlyte, please visit their website.